Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 9/20 | 0.46 |
| ▸ | CNR2 | P34972 | 2/20 | 0.44 |
| ▸ | KDM1A | O60341 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.42 |
| ▸ | IKBKB | O14920 | 1/20 | 0.42 |
| ▸ | CHUK | O15111 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CDK1 | P06493 | 1/20 | 0.39 |
| ▸ | KDR | P35968 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8098730 | 0.96 | CNR1 (0.44) | CNR1CNR2KDM1APTGS2PTGS1 | |
| SCHEMBL8101167 | 0.96 | PTGS2 (0.45) | CNR1CNR2KDM1APTGS2PTGS1 | |
| SCHEMBL8094910 | 0.95 | PTGS2 (0.46) | CNR1CNR2KDM1APTGS2PTGS1 | |
| SCHEMBL8099978 | 0.90 | PTGS2 (0.52) | CNR1CNR2KDM1APTGS2PTGS1 | |
| SCHEMBL8094551 | 0.87 | CNR1 (0.49) | CNR1CNR2PTGS2PTGS1CA12 | |
| SCHEMBL8093970 | 0.87 | PTGS2 (0.54) | CNR1CNR2KDM1APTGS2PTGS1 | |
| SCHEMBL8101431 | 0.87 | PTGS2 (0.56) | CNR1CNR2KDM1APTGS2PTGS1 | |
| SCHEMBL8086461 | 0.86 | CNR1 (0.61) | CNR1CNR2PTGS2PTGS1CA12 | |
| SCHEMBL8101755 | 0.86 | PTGS2 (0.58) | CNR1CNR2KDM1APTGS2PTGS1 | |
| SCHEMBL8094547 | 0.84 | PTGS2 (0.60) | CNR1CNR2PTGS2PTGS1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0808304-B1 | 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2000-12-27 | — | — | EP | disclosed |
| EP-0808304-A1 | 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1997-11-26 | — | — | EP | disclosed |
| WO-1996024584-A1 | 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-08-15 | — | — | WO | disclosed |